Astellas Pharma has struck a drug discovery deal worth up to $100 million per target with X-Chem.

Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech.

As Donald Trump is sworn into office today, we look at what the next 100 days and indeed the next four years could mean for the biopharma industry through his…

Evotec and MaRS Innovation have joined forces to found Fibrocor Therapeutics, a fibrotic disease startup.

Neurimmune and TVM Capital Life Science have partnered to create and fund a single-asset biotech focused on amyotrophic lateral sclerosis.

An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…

After a 13-year run at FierceBiotech, I’m stepping aside as editor-in-chief of our plucky, global band of life sciences reporters.

Ipsen has strengthened its connection to Oncodesign, the French oncology specialist that lists Bristol-Myers Squibb among its partners.